FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1144477009: Relugolix (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
4542089017 Relugolix (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
4542090014 Relugolix en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Relugolix Has disposition Gonadotropin releasing hormone receptor antagonist true Inferred relationship Existential restriction modifier
Relugolix Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Relugolix Is a Substance with gonadotropin releasing hormone receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Relugolix Is a Substance with benzene structure true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing relugolix (medicinal product) Has active ingredient True Relugolix Inferred relationship Existential restriction modifier 1
Product containing only relugolix (medicinal product) Has active ingredient True Relugolix Inferred relationship Existential restriction modifier 1
Product containing relugolix in oral dose form (medicinal product form) Has active ingredient True Relugolix Inferred relationship Existential restriction modifier 1
Product containing only relugolix in oral dose form (medicinal product form) Has active ingredient True Relugolix Inferred relationship Existential restriction modifier 1
Product containing precisely relugolix 120 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Relugolix Inferred relationship Existential restriction modifier 1
Product containing precisely relugolix 120 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Relugolix Inferred relationship Existential restriction modifier 1
Relugolix 120mg tablets Has specific active ingredient True Relugolix Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 84 tablet 3 x 28 tablets Has specific active ingredient True Relugolix Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Has specific active ingredient True Relugolix Inferred relationship Existential restriction modifier
Generic Ryeqo 40mg/1mg/0.5mg tablets 28 tablet Has specific active ingredient True Relugolix Inferred relationship Existential restriction modifier
Generic Ryeqo 40mg/1mg/0.5mg tablets Has specific active ingredient True Relugolix Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) Has specific active ingredient True Relugolix Inferred relationship Existential restriction modifier
Generic Ryeqo 40mg/1mg/0.5mg tablets 84 tablet Has specific active ingredient True Relugolix Inferred relationship Existential restriction modifier
Orgovyx 120mg tablets (Accord Healthcare Ltd) 30 tablet Has specific active ingredient True Relugolix Inferred relationship Existential restriction modifier
Orgovyx 120mg tablets (Accord Healthcare Ltd) Has specific active ingredient True Relugolix Inferred relationship Existential restriction modifier
Relugolix 120mg tablets 30 tablet Has specific active ingredient True Relugolix Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start